Results 201 to 210 of about 1,424,891 (239)
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel +8 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
From medical student to Editor: A note of thanks
Ca-A Cancer Journal for Clinicians, 2023Ted Gansler
exaly

